Lasa Supergenerics Ltd - 540702 - Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015.
Pursuant to Regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 please find enclosed herewith Disclosure of Related Party Transactions for the half year ended September 30, 2022 Lasa Supergenerics Ltd - 540702 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. November 14, 2022
Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 p.m. and concluded at 3.30 p.m. inter- alia have considered and approved the following: 1. The statement of unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2022. 2. Limited Review Report from Statutory Auditor for the quarter and half year ended on September 30, 2022. Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Board Meeting Intimation For Meeting Scheduled On 14/11/2022.
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve and take on record Un-audited financial results along with limited review report for the quarter and half year ended September 30, 2022 and / or to discuss and any other business / matter with the permission of chair. Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita ShettyDesignation :- Company Secretary and Compliance Officer Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2022 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company. Lasa Supergenerics Ltd - 540702 - Closure of Trading Window
This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. October 01, 2022 till 48 hours after the declaration of unaudited financial results (both days inclusive) for the quarter & half year ended on September 30, 2022. Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In terms of the subject referred, the details regarding consolidated voting results of the business transacted at the 7th Annual General Meeting (AGM) of the Company held on Monday, 26th September, 2022 is annexed herewith for your reference and records. The Company had appointed M/s Amit R. Dadheech & Associates as the Scrutinizer for remote e-Voting and e-Voting conducted at the AGM. As per the Scrutinizer's Report, all the Resolutions as set out in the Notice of 7th AGM have been duly approved by the Members with requisite majority. Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, as amended, we are submitting herewith the summary of proceedings of the 7th Annual General Meeting of the Company held on Monday, 26th September, 2022 at 09:30 a.m. Indian Standard Time ('IST'), which concluded at 10:15 am (including time allowed for e-voting at the AGM) through Video Conferencing/ Other Audio Visual Means ('VC/OAVM'). The Meeting was held in compliance with the General Circulars issued by the Ministry of Corporate Affairs (MCA) and Circular issued by the Securities and Exchange Board of India (SEBI) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder. Lasa Supergenerics Ltd - 540702 - Reg. 34 (1) Annual Report.
Annual Report for the financial year ended March 31, 2022 along with Notice of the Seventh (7th ) Annual General Meeting and Cut-off Date for the purpose of E voting and Dividend. Lasa Supergenerics Ltd - 540702 - Compliance Of Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Intimation Of Book Closure And Record Date
The Record Date for determining the members eligible to receive the aforesaid dividend will be 19 September 2022. The Dividend will be paid to those Shareholders whose name appears on the Register of Members as on 19th September 2022 in respect of the shares held in the physical form. In respect of shares held in dematerialized form dividend will be paid on the basis of beneficial ownership as per the details provided by the Depositories for this purpose as at the end of the business hours on 19th September 2022.